Neuro-Oncology
Reviews


Volume 24 Number 16
31 August 2022


Home > Publications > Neuro-Oncology Reviews > Volume 24, Year 2022 > Number 16, 31 August





*

Swildens KX, Sillevis Smitt PAE, van den Bent MJ, French PJ, Geurts M.
The effect of dexamethasone on the microenvironment and efficacy of checkpoint inhibitors in glioblastoma: a systematic review.
Neurooncol Adv. 2022 Jun 7, 2022;4(1):vdac087
. doi: 10.1093/noajnl/vdac087. PMID: 35990704. Review.




Fang Y, Zhang G, Bai Z, Yan Y, Song X, Zhao X, Yang P, Zhang Z.
Low-intensity ultrasound: A novel technique for adjuvant treatment of gliomas.
Biomed Pharmacother. 2022 Jul 13, 2022;153:113394. doi: 10.1016/j.biopha.2022.113394. PMID: 36036428. Review.




Zhang W, Jiang J, He Y, Li X, Yin S, Chen F, Li W.
Association between vitamins and risk of brain tumors: A systematic review and dose-response meta-analysis of observational studies.
Front Nutr. 2022 Jul 29, 2022;9:935706
. doi: 10.3389/fnut.2022.935706. PMID: 35967781. Review and Meta-analysis.








Leone A, Colamaria A, Fochi NP, Sacco M, Landriscina M, Parbonetti G, de Notaris M, Coppola G, De Santis E, Giordano G, Carbone F.
Recurrent Glioblastoma Treatment: State of the Art and Future Perspectives in the Precision Medicine Era.
Biomedicines. 2022 Aug 9, 2022;10(8):1927
. doi: 10.3390/biomedicines10081927. PMID: 36009473. Review.




Hatoum R, Chen JS, Lavergne P, Shlobin NA, Wang A, Elkaim LM, Dodin P, Couturier CP, Ibrahim GM, Fallah A, Venne D, Perreault S, Wang AC, Jabado N, Dudley RWR, Weil AG.
Extent of Tumor Resection and Survival in Pediatric Patients With High-Grade Gliomas: A Systematic Review and Meta-analysis.
JAMA Netw Open. 2022 Aug 16, 2022;5(8):e2226551. doi: 10.1001/jamanetworkopen.2022.26551. PMID: 35972743. Review and Meta-analysis.




Zhang D, Zhu W, Guo J, Chen W, Gu X.
Application of artificial intelligence in glioma researches: A bibliometric analysis.
Front Oncol. 2022 Aug 11, 2022;12:978427. doi: 10.3389/fonc.2022.978427. PMID: 36033537. Bibliometric analysis.




Omuro A.
Immune-checkpoint inhibitors for glioblastoma: what have we learned?
Arq Neuropsiquiatr. 2011 Aug 12, 2022;80(5 Suppl 1):266-269. doi: 10.1590/0004-282X-ANP-2022-S129. PMID: 35976319. Review.




Upadhyay R, Yadav D, Venkatesulu BP, Singh R, Baliga S, Raval RR, Lazow MA, Salloum R, Fouladi M, Mardis ER, Zaorsky NG, Trifiletti DM, Paulino AC, Palmer JD.
Risk of secondary malignant neoplasms in children following proton therapy vs. photon therapy for primary CNS tumors: A systematic review and meta-analysis.
Front Oncol. 2022 Aug 12, 2022;12:893855. doi: 10.3389/fonc.2022.893855. PMID: 36033525. Review and Meta-analysis.




Liang S, Fan X, Chen F, Liu Y, Qiu B, Zhang K, Qi S, Zhang G, Liu J, Zhang J, Wang J, Wang X, Song Z, Luan G, Yang X, Jiang R, Zhang H, Wang L, You Y, Shu K, Lu X, Gao G, Zhang B, Zhou J, Jin H, Han K, Li Y, Wei J, Yang K, You G, Ji H, Jiang Y, Wang Y, Lin Z, Li Y, Liu X, Hu J, Zhu J, Li W, Wang Y, Kang D, Feng H, Liu T, Chen X, Pan Y, Liu Z, Li G, Li Y, Ge M, Fu X, Wang Y, Zhou D, Li S, Jiang T, Hou L, Hong Z.
Chinese guideline on the application of anti-seizure medications in the perioperative period of supratentorial craniocerebral surgery.
Ther Adv Neurol Disord. 2022 Aug 16, 2022;15:17562864221114357. doi: 10.1177/17562864221114357. PMID: 35992894. Guidelines.




Shams S, Patel CB.
Anti-cancer mechanisms of action of therapeutic alternating electric fields (tumor treating fields [TTFields]).
J Mol Cell Biol. 2022 Aug 16, 2022:mjac047
. doi: 10.1093/jmcb/mjac047. PMID: 35973687. Review.




Zhang HM, Huo XB, Wang HL, Wang C.
Diagnostic Performance of Dynamic Susceptibility Contrast-Enhanced Perfusion-Weighted Imaging in Differentiating Recurrence From Radiation Injury in Postoperative Glioma: A Meta-analysis.
J Comput Assist Tomogr. 2022 Aug 16. doi: 10.1097/RCT.0000000000001356. PMID: 35969866. Meta-analysis
˰




Cao TQ, Wainwright DA, Lee-Chang C, Miska J, Sonabend AM, Heimberger AB, Lukas RV.
Next Steps for Immunotherapy in Glioblastoma.
Cancers (Basel). 2022 Aug 20, 2022;14(16):4023. doi: 10.3390/cancers14164023. PMID: 36011015. Review.




Rizzo A, Dall'Armellina S, Pizzuto DA, Perotti G, Zagaria L, Lanni V, Treglia G, Racca M, Annunziata S.
PSMA Radioligand Uptake as a Biomarker of Neoangiogenesis in Solid Tumours: Diagnostic or Theragnostic Factor?
Cancers (Basel). 2022 Aug 21, 2022;14(16):4039. doi: 10.3390/cancers14164039. PMID: 36011032. Review.




Hanganu B, Lazar DE, Manoilescu IS, Mocanu V, Butcovan D, Buhas CL, Szalontay AS, Ioan BG.
Controversial Link between Cannabis and Anticancer Treatments-Where Are We and Where Are We Going? A Systematic Review of the Literature.
Cancers (Basel). 2022 Aug 22, 2022;14(16):4057. doi: 10.3390/cancers14164057. PMID: 36011049. Review.




Prieto R, Hofecker V, Corbacho C.
Coexisting lipomatous meningioma and glioblastoma in Cowden syndrome: A unique tumor association.
Neuropathology. 2022 Aug 24
. doi: 10.1111/neup.12858. PMID: 36003032. Case report and Review˰




Berger TR, Wen PY, Lang-Orsini M, Chukwueke UN.
World Health Organization 2021 Classification of Central Nervous System Tumors and Implications for Therapy for Adult-Type Gliomas: A Review.
JAMA Oncol. 2022 Aug 25. doi: 10.1001/jamaoncol.2022.2844. PMID: 36006639. Review
˰




Bernhardt D, König L, Grosu A, Wiestler B, Rieken S, Wick W, Gempt J, Krieg SM, Schmidt-Graf F, Sahm F, Meyer B, Krause BJ, Petersen C, Fietkau R, Thomas M, Giordano F, Wittig-Sauerwein A, Debus J, Tabatabai G, Hau P, Steinbach J, Combs SE; Expert Panel of the German Society of Radiation Oncology (DEGRO).
DEGRO practical guideline for central nervous system radiation necrosis part 1: classification and a multistep approach for diagnosis.
Strahlenther Onkol. 2022 Aug 29. doi: 10.1007/s00066-022-01994-3. PMID: 36038669. Guidelines.




Bernhardt D, König L, Grosu AL, Rieken S, Krieg SM, Wick W, Wiestler B, Schmidt-Graf F, Sahm F, Gempt J, Meyer B, Krause BJ, Petersen C, Fietkau R, Thomas M, Giordano F, Wittig-Sauerwein A, Debus J, Tabatabai G, Hau P, Steinbach J, Combs SE; Expert Panel of the German Society of Radiation Oncology (DEGRO).
DEGRO practical guideline for central nervous system radiation necrosis part 2: treatment.
Strahlenther Onkol. 2022 Aug 29. doi: 10.1007/s00066-022-01973-8. PMID: 36038670. Guidelines.